• Home
  •  
    Regions
    • Europe
    • UK & Ireland
    • DACH
    • Nordic
    • France
    • Southern Europe
    • Benelux
    • CEE
    • Asia
  •  
    Deals
    • Buyouts
    • Venture
    • Exits
    • Refinancings
    • Build-up
    • Turnaround
    • Secondaries
    • Advanced deals search
  •  
    Funds
    • Buyout
    • Venture
    • Mezzanine
    • Debt
    • Funds-of-funds
    • Secondaries
    • Fundraising pipelines
    • Advanced funds search
  •  
    GPs & LPs
    • GP profiles
    • LP profiles
    • GP news
    • LP news
    • Sponsors search
    • LPs search
  •  
    Secondaries
    • Deals
    • Funds
    • News
    • Analysis
  •  
    People
    • People moves
    • Analysis
    • In Profile
    • Q&A
    • Videos
    • Comment
  •  
    Analysis
    • In Profile
    • Fundraising
    • Q&A
    • Comment
    • Videos
    • Podcast
    • Reports
    • Data Snapshots
  •  
    Unquote Data
    • Deals search
    • Exits search
    • Funds search
    • Sponsors search
    • Advisers search
    • LPs search
    • League tables
    • Reports
  • Sign in
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)203 741 1137

      Email: Georgina.Lawson@acuris.com

      • Sign in
     
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • Twitter
    • LinkedIn
  • Free Trial
  • Subscribe
Unquote
Unquote
  • Home
  • Regions
  • Deals
  • Funds
  • GPs & LPs
  • Secondaries
  • People
  • Analysis
  • Unquote Data
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)203 741 1137

    Email: Georgina.Lawson@acuris.com

    • Sign in
 
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 
Unquote
  • Exits

PM & Partners sells Plastiape for c€150m

  • Amedeo Goria
  • Amedeo Goria
  • 21 November 2016
  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  

Italian mid-market buyout house PM & Partners has sold its stake in pharmaceutical and cosmetic packaging manufacturer Plastiape in a trade sale.

As part of the deal, the GP sold its stake to the British listed corporate RPC Group via an on-the-market transaction. According to a source familiar with the transaction, the deal valued the business at approximately €150m EV. Moreover, the GP claimed to reap return multiples in line with the sector standards.

Investment banks Baird and Banca Imi co-led an auction process for the sale, launched in July 2016, which saw several private equity funds as well as corporates show interest in Plastiape.

Plastiape

  • DEAL:

    Exit

  • VALUE:

    €150m EV est

  • LOCATION:

    Lecco

  • SECTOR:

    Industrial supplies

  • FOUNDED:

    1969

  • TURNOVER:

    €55m

  • EBITDA:

    €12.5m

  • STAFF:

    300

  • VENDOR:

    PM & Partners

Previous funding
In 2008, Italian GP Aksía Group bought a 53.9% stake in the firm in an LBO valued at more than €40m, with €20m of equity. As part of the deal, Banca Popolare di Milano and Interbanca underwrote the €18m senior debt that also included the refinancing of Plastiape's previous debt facilities.

In June 2013, PM & Partners acquired a 77.67% stake in the business via its vehicle PM & Partners II. The deal valued the business at €71m EV, which equalled a 7x multiple of the company's EBITDA for 2012. Aksía scored a 3x money multiple on its exit. As part of the deal, the owning Citterio and Magni families retained a 10.23% and 7.8% stake in the business, respectively. The management team bought the remaining 3.8% stake.

In 2015, the company enacted a €40m recapitalisation plan led by GE Capital, alongside Ubi Banca and Banca Popolare dell'Emilia Romagna, to increase liquidity. As part of the refinancing, the GP is understood to have used part of the proceeds to pay back 50% of its original investment to LPs.

Company
Founded in 1969 and headquartered in Lecco, Plastiape operates in the packaging sector mainly for the pharmaceutical, personal care products and medical devices sectors, including dry powder inhalers.

According to the source, the company generated €55m in revenues with €12.5m EBITDA in 2015. The business employs 300 people and also has a presence in Poland.

People
PM & Partners – Andrea Mugnai, Andrea Sagone, Francesco Panfilo (managing partners).
Plastiape – Giulio Agostini (chair); Alfredo Masuello (CEO).

  • Tweet  
  • Facebook  
  • LinkedIn  
  • Google plus  
  • Send to  
  • Topics
  • Exits
  • Industrials
  • Southern Europe
  • Trade sale
  • Italy
  • PM & Partners

More on Exits

Public sector software
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • Exits
  • 04 September 2023
Lender taking the keys from a sponsor
Ares Management handed keys to two-thirds of UK sponsor’s portfolio

Lender provided GBP 500m for three of the GP's deals between 2016 and 2019, Debtwire reported

  • Financing
  • 30 August 2023
Luggage and airport services
Actera Group explores strategic options for Celebi Ground Handling

Several investors placed bids for the company in 2022 but mismatch in pricing didn't lead to a deal

  • Exits
  • 30 August 2023
HR software solutions providers
Main Capital’s Assessio to be sold to Pollen Street

Recruitment software company tripled in revenue under Main Capital’s ownership

  • Buyouts
  • 25 August 2023

Latest News

Fund closes in US dollars
  • Funds
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme

Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote

  • 05 September 2023
Clinical trials and biotechnology
  • Buyouts
Permira to take Ergomed private for GBP 703m

Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO

  • 04 September 2023
Public sector software
  • Exits
Partners Group to release IMs for Civica sale in mid-September

Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017

  • 04 September 2023
EMEA Public to Private M&A
  • Investments
Change of mind: Sponsors take to de-listing their own assets

EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater

  • 04 September 2023
Back to Top
  • About Unquote
  • Advertise
  • Contacts
  • About Acuris
  • Terms of Use
  • Privacy Policy
  • Group Disclaimer
  • Twitter
  • LinkedIn

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013